Company research / LCTC

Lifeloc Technologies, Inc (LCTC)

CIK 0001493137 · OTC · Laboratory Analytical Instruments

  • Sector Manufacturing
  • Incorporated CO
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Lifeloc Technologies, Inc reported revenue of $9.03M. Revenue grew 5.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $9.27M.

Key ratios (year ended 2025-12-31)

40.3%
Gross margin
-13.6%
Operating margin
-27.4%
Net margin
-60.2%
Return on year-end equity
5.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-29

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$9.27M$9.03M$8.54M$9.33M$8.48M$7.05M$6.36M$8.75M$8.44M$7.99M$8.38M
Cost of Revenue$5.38M$5.38M$5.09M$5.29M$5.41M$3.99M$4.18M$4.82M$4.63M$4.28M$4.20M
Gross Profit$3.89M$3.64M$3.45M$4.04M$3.07M$3.06M$2.18M$3.94M$3.81M$3.71M$4.18M
R&D Expense$2.03M$2.15M$2.24M$1.84M$1.39M$1.21M$1.01M$1.04M$1.12M$1.08M$1.04M
Operating Income-$802.8K-$1.23M-$1.41M-$191.1K-$650.3K-$268.9K-$1.16M$481.2K$270.6K$132.6K$635.0K
Depreciation & Amortization$363.0K$443.5K$294.0K$264.8K$632.4K$254.8K$364.3K$412.5K$416.9K$288.0K$283.2K
EBITDA-$439.8K-$786.6K-$1.11M$73.7K-$17.9K-$14.1K-$791.2K$893.7K$687.5K$420.7K$918.1K
Net Income-$2.07M-$2.47M-$1.05M$205.6K-$455.8K$676.0K-$921.9K$625.8K$217.2K$14.6K$433.2K
EPS (Diluted)n/a-$0.90-$0.41$0.08-$0.19$0.27-$0.38$0.26$0.09$0.01$0.17
Total Assets$7.08M$6.69M$8.72M$8.69M$8.52M$8.95M$8.54M$9.02M$8.28M$8.09M$8.07M
Total Liabilities$3.26M$2.58M$2.50M$2.33M$2.36M$2.36M$2.64M$2.23M$2.12Mn/an/a
Shareholders' Equity$3.82M$4.10M$6.23M$6.36M$6.16M$6.59M$5.90M$6.79M$6.16M$5.93M$5.89M
Cash & Equivalentsn/an/an/an/an/a$2.57M$2.20M$3.19M$2.79M$2.67M$3.77M
Operating Cash Flow-$372.3K-$499.3K-$1.33M-$525.7K$54.3K$182.9K-$1.36M$698.9K$570.3K-$181.3K$631.3K
Capital Expendituresn/a$462.8K$539.7K$6.8K$213.2K$265.9K$27.5K$256.9K$402.1K$11.8K$42.8K
Free Cash Flown/a-$962.1K-$1.87M-$532.6K-$158.9K-$82.9K-$1.39M$442.0K$168.2K-$193.1K$588.5K
Shares Outstanding2.75M2.75M2.66M2.45M2.45M2.45M2.45M2.45M2.45M2.45M2.45M
Weighted Average Diluted Sharesn/a2.74M2.55M2.45M2.45M2.52M2.45M2.45M2.51M2.52M2.55M
EPS (Basic)n/a-$0.90-$0.41$0.08-$0.19$0.28-$0.38$0.26$0.09$0.01$0.18